Newsbenzinga
Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript
· Published
Article summary
Vivos Therapeutics (NASDAQ:VVOS) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
An excerpt from the original article.
Comments —
Loading comments…